Clinical Trials About "Oswald Companies" RSS

05:02 EST 19th November 2018 | BioPortfolio

We list hundreds of Clinical Trials about "Oswald Companies" on BioPortfolio. We draw our references from global clinical trials data listed on and refresh our database daily.

More Information about "Oswald Companies" on BioPortfolio

We have published hundreds of Oswald Companies news stories on BioPortfolio along with dozens of Oswald Companies Clinical Trials and PubMed Articles about Oswald Companies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oswald Companies Companies in our database. You can also find out about relevant Oswald Companies Drugs and Medications on this site too.

Showing "Oswald Companies" Clinical Trials, all 5

Probably Relevant

Physician Disclosures in the Real World of Conflicting Interests

This study seeks to ascertain the best way to inform patients about their physicians' conflicts of interest (COI) with industry. Currently, there is no institutional or national standard for such physician-to-patient disclosures. The primary aim of this study is to test different written disclosures and assess their impact on patients' knowledge of their physicians' COIs and on patients' trust in their physician and their healthcare institution. The secondary aim is to investig...

Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma

Asthma is a chronic disease of the lungs characterized by airway inflammation, bronchoconstriction and increased airway responsiveness. Inhaled corticosteroids (ICS), alone or in combination with inhaled long-acting beta-adrenergic agonists (LABA), are considered a mainstay of treatment for treatment. For inhaled medications, the choice of inhalation device is an important consideration because an inadequate technique reduces the delivery of medicines and effects of inhalation....

Ease of Use and Correct Use Study of Placebo ELLIPTA® Inhaler in COPD Subjects

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease characterized by airflow limitation that is not fully reversible. The mainstay for treatment involves the use of inhaled medications, including short and/or long-acting bronchodilators along with inhaled corticosteroids. For inhaled medications, the choice of inhalation device is an important consideration because an inadequate technique reduces the effects of inhalation. Therefore, the developm...

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Pe

This study is a randomized, double-blind, double-dummy, parallel group, multicenter, non-inferiority study. The study will enroll adult and adolescent asthmatic subjects who are currently receiving mid dose inhaled corticosteroids (ICS) plus long-acting beta2-agonist (LABA) (equivalent to fluticasone propionate [FP]/salmeterol 250/50 microgram [mcg]twice daily [BD]), either via a fixed dose combination product or through separate inhalers. The study consists of a LABA washout p...

Possibly Relevant

Mindfulness Training for Smoking Cessation in Women in Workplaces

This study has the following objectives: 1. To raise the awareness of female smokers about the harmfulness of tobacco towards their life issues 2. To encourage female smokers to stop using tobacco 3. To assess the effectiveness of mindfulness approach for smoking cessation in women We will use cluster randomisation. About 40 companies (5 smokers / company) involved in the study will be matched on the company characteristics (e.g. company size, the industry ...

More From BioPortfolio on "Oswald Companies"

Quick Search